[MYGN] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
08-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 591.67%
YoY- -80.53%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 195,100 216,800 194,000 196,500 193,300 184,393 204,060 -0.74%
PBT -11,400 3,600 3,700 12,100 45,000 37,940 84,144 -
Tax -3,100 1,000 -28,400 6,200 14,700 13,909 33,784 -
NP -8,300 2,600 32,100 5,900 30,300 24,031 50,360 -
Tax Rate - -27.78% 767.57% -51.24% -32.67% -36.66% -40.15% -
Total Cost 203,400 214,200 161,900 190,600 163,000 160,362 153,700 4.77%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -4.25 1.20 16.55 3.00 15.68 13.03 24.68 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.11 0.04 0.46 0.09 0.43 0.33 0.67 -
EPS Diluted -0.11 0.03 0.45 0.09 0.41 0.32 0.66 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.